文献速递重症综合管理与镇静镇痛心脑血管急症

脓毒症与接受静脉-动脉体外膜氧合治疗的成人患者神经功能结局的相关性

Association of Sepsis With Neurologic Outcomes of Adult Patients Treated With Venoarterial Extracorporeal Membrane Oxygnenation.
PubMed 文献 · Crit Care Explor · 2024-02-07
一句话结论在VA-ECMO前发生心脏骤停的患者中,合并脓毒症与90天不良功能结局独立相关(校正OR 3.44),但未发生心脏骤停者无此关联。

法国一所大学医院医学ICU 2013–2020年单中心暴露-非暴露队列研究,连续纳入196例接受VA-ECMO的成人患者,比较插管时合并脓毒症(128例)与未合并脓毒症(68例)者。主要终点90天不良功能结局(mRS≥4)在脓毒症组77.3%、无脓毒症组67.6%,总体校正OR 1.21(95%CI 0.58–2.47)、IPTW OR 1.24(95%CI 0.79–1.95),未达统计学显著。按ECMO前心脏骤停状态分层后,心脏骤停亚组中脓毒症与不良结局独立相关(校正OR 3.44,95%CI 1.06–11.40;IPTW OR 3.52,95%CI 1.68–7.73),无心脏骤停亚组无此关联(校正OR 0.69,95%CI 0.27–1.69;IPTW OR 0.76,95%CI 0.42–1.35)。脓毒症组第1天S100β更高(0.94 μg/L vs 0.52 μg/L,p=0.03)且EEG异常更常见,提示脑损伤。

要点

  • VA-ECMO插管时合并脓毒症者90天不良功能结局(mRS≥4)为77.3%(99/128),无脓毒症者为67.6%(46/68),总体校正OR 1.21(95%CI 0.58–2.47)、IPTW OR 1.24(95%CI 0.79–1.95),未达统计学显著。
  • ECMO前发生心脏骤停的亚组中,脓毒症与90天不良功能结局独立相关:校正OR 3.44(95%CI 1.06–11.40),IPTW OR 3.52(95%CI 1.68–7.73)。
  • ECMO前未发生心脏骤停的亚组中,脓毒症与90天不良功能结局无显著关联:校正OR 0.69(95%CI 0.27–1.69),IPTW OR 0.76(95%CI 0.42–1.35)。
  • 脓毒症组第1天S100β浓度高于无脓毒症组(0.94 μg/L vs 0.52 μg/L,p=0.03),EEG异常(严重慢波、背景不连续、睡眠模式出现率更低)更常见,提示脑损伤。
  • 196例中87例(44.4%)在VA-ECMO插管前发生心脏骤停;脓毒症与神经功能结局的关联仅见于该亚组。

适用人群与场景

  • 法国一所大学医院医学ICU 2013–2020年连续接受VA-ECMO治疗的成人患者。
  • 按VA-ECMO插管时是否合并脓毒症分为「脓毒症」组(n=128)与「无脓毒症」组(n=68);196例中87例(44.4%)在VA-ECMO插管前发生心脏骤停。

诊断标准与关键阈值

  • 主要结局为90天不良功能结局,定义为改良Rankin量表(mRS)评分≥4分,即严重残疾或死亡。
  • 暴露定义为VA-ECMO插管时合并脓毒症。

红旗征与不能漏的情况

  • VA-ECMO插管时合并脓毒症且ECMO前发生心脏骤停者,90天不良功能结局风险更高(校正OR 3.44,95%CI 1.06–11.40;IPTW OR 3.52,95%CI 1.68–7.73)。
  • 脓毒症组第1天S100β升高(0.94 μg/L vs 0.52 μg/L,p=0.03)及EEG异常(严重慢波、背景不连续、睡眠模式出现率更低),提示脑损伤。

研究设计与关键结果

  • 单中心暴露-非暴露队列研究,纳入196例VA-ECMO成人患者,脓毒症组128例、无脓毒症组68例;主要终点90天mRS≥4在脓毒症组99/128(77.3%)、无脓毒症组46/68(67.6%),校正logistic回归OR 1.21(95%CI 0.58–2.47),IPTW OR 1.24(95%CI 0.79–1.95)。
  • ECMO前心脏骤停亚组中,脓毒症与90天不良功能结局独立相关:校正logistic回归OR 3.44(95%CI 1.06–11.40),IPTW OR 3.52(95%CI 1.68–7.73)。
  • ECMO前无心脏骤停亚组中,脓毒症与90天不良功能结局无显著关联:校正logistic回归OR 0.69(95%CI 0.27–1.69),IPTW OR 0.76(95%CI 0.42–1.35)。
  • 与无脓毒症组相比,脓毒症组第1天S100β浓度显著升高(0.94 μg/L vs 0.52 μg/L,p=0.03),EEG异常(严重慢波、背景不连续、睡眠模式出现率更低)更常见。

证据类型、等级与局限

  • 单中心队列研究(暴露-非暴露设计)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,脓毒症对神经功能结局的不利作用见于VA-ECMO前发生心脏骤停的患者亚组,而不见于其他患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Neurologic outcomes of patients under venoarterial extracorporeal membrane oxygenation (VA-ECMO) may be worsened by secondary insults of systemic origin. We aimed to assess whether sepsis, commonly observed during ECMO support, is associated with brain injury and outcomes.

DESIGN: Single-center cohort study of the "exposed-non-exposed" type on consecutive adult patients treated by VA-ECMO.

SETTING: Medical ICU of a university hospital, France, 2013-2020.

PATIENTS: Patients with sepsis at the time of VA-ECMO cannulation ("sepsis" group) were compared with patients without sepsis ("no sepsis" group). The primary outcome measure was poor functional outcome at 90 days, defined by a score greater than or equal to 4 on the modified Rankin scale (mRS), indicating severe disability or death.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: A total of 196 patients were included ("sepsis," n = 128; "no sepsis," n = 68), of whom 87 (44.4%) had presented cardiac arrest before VA-ECMO cannulation. A poor functional outcome (mRS ≥ 4) was observed in 99 of 128 patients (77.3%) of the "sepsis" group and 46 of 68 patients (67.6%) of the "no sepsis" group (adjusted logistic regression odds ratio (OR) 1.21, 95% CI, 0.58-2.47; inverse probability of treatment weighting (IPTW) OR 1.24; 95% CI, 0.79-1.95). Subsequent analyses performed according to pre-ECMO cardiac arrest status suggested that sepsis was independently associated with poorer functional outcomes in the subgroup of patients who had experienced pre-ECMO cardiac arrest (adjusted logistic regression OR 3.44; 95% CI, 1.06-11.40; IPTW OR 3.52; 95% CI, 1.68-7.73), whereas no such association was observed in patients without pre-ECMO cardiac arrest (adjusted logistic regression OR 0.69; 95% CI, 0.27-1.69; IPTW OR 0.76; 95% CI, 0.42-1.35). Compared with the "no sepsis" group, "sepsis" patients presented a significant increase in S100 calcium-binding protein beta concentrations at day 1 (0.94 μg/L vs. 0.52 μg/L, p = 0.03), and more frequent EEG alterations (i.e., severe slowing, discontinuous background, and a lower prevalence of sleep patterns), suggesting brain injury.

CONCLUSION: We observed a detrimental role of sepsis on neurologic outcomes in the subgroup of patients who had experienced pre-ECMO cardiac arrest, but not in other patients.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Tridon C, Bachelet D, El Baied M, et al. Association of Sepsis With Neurologic Outcomes of Adult Patients Treated With Venoarterial Extracorporeal Membrane Oxygnenation. Crit Care Explor. 2024. PMID: 38333077. doi:10.1097/CCE.0000000000001042

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。